0000785161-26-000130
SEC filingVolume growth and favorable pricing drove a 9.0% revenue increase, resulting in 28.4% net income expansion. The performance reflects successful execution on core operational drivers and demand tailwinds.
Encompass Health reported consolidated net operating revenues of $1.6 billion for the first quarter of 2026, a 9.0% increase compared to the same period in 2025. This topline growth was primarily driven by increased volumes and favorable pricing dynamics. Specifically, growth in net patient revenue per discharge resulted from an increase in reimbursement rates, retroactive cost reporting adjustments, and favorable patient mix. The company noted that the addition of hospitals to its portfolio remains a strategic priority, though new-store volume growth can be difficult and take longer than expected to realize.
Net income rose to $194.5 million, representing a 28.4% increase year-over-year, while diluted EPS reached $1.93, up 30.4%. The significant expansion in profitability reflects operating leverage gained from the revenue growth. The increase in net income underscores the company's ability to translate volume and pricing improvements into bottom-line results. Management expects depreciation and amortization to increase going forward as a result of recent and ongoing capital investments, which may moderate future margin expansion.
The increase in net cash provided by operating activities for the three months ended March 31, 2026, compared to the same period in 2025, primarily resulted from the increase in net income, which was itself driven by growth in net operating revenues. The objectives of the company's capital structure strategy are to ensure it maintains adequate liquidity and flexibility. Capital expenditures are directed toward a hospital renovation program, de novo projects, capacity expansions, technology initiatives, and building and equipment upgrades.
The company operates in a favorable demand environment, with most patients aged 65 and older. Management believes the demand for the services provided will continue to increase as the U.S. population ages, and the number of Medicare enrollees is expected to continue growing for the foreseeable future. This demographic tailwind supports the company's ongoing development activities and capacity expansion initiatives.